SES - Delayed Quote • SGD
Thomson Medical Group Limited (A50.SI)
At close: April 26 at 5:04 PM GMT+8
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
Total Revenue
339,888.0000
355,769.0000
333,706.0000
240,398.0000
Cost of Revenue
60,096.0000
59,380.0000
55,321.0000
49,502.0000
Gross Profit
279,792.0000
296,389.0000
278,385.0000
190,896.0000
Operating Expense
215,587.0000
214,405.0000
186,578.0000
142,084.0000
Operating Income
64,205.0000
81,984.0000
91,807.0000
48,812.0000
Net Non Operating Interest Income Expense
-29,968.0000
-26,564.0000
-22,509.0000
-22,630.0000
Pretax Income
34,171.0000
55,203.0000
69,298.0000
26,182.0000
Tax Provision
12,464.0000
14,147.0000
10,713.0000
9,272.0000
Net Income Common Stockholders
15,778.0000
36,555.0000
53,762.0000
14,237.0000
Diluted NI Available to Com Stockholders
15,778.0000
36,555.0000
53,762.0000
14,237.0000
Basic EPS
0.00
0.00
0.00
0.00
Diluted EPS
0.00
0.00
0.00
0.00
Basic Average Shares
26,441,067.0000
26,441,067.0000
26,441,067.0000
26,441,067.0000
Diluted Average Shares
26,455,660.8000
26,446,738.0000
26,441,067.0000
26,441,067.0000
Total Operating Income as Reported
64,481.0000
82,260.0000
91,807.0000
48,812.0000
Total Expenses
275,683.0000
273,785.0000
241,899.0000
191,586.0000
Net Income from Continuing & Discontinued Operation
15,778.0000
36,555.0000
53,762.0000
14,237.0000
Normalized Income
15,602.6720
36,349.7312
53,762.0000
14,237.0000
Interest Income
7,420.0000
3,948.0000
988.0000
980.0000
Interest Expense
37,388.0000
30,512.0000
23,497.0000
23,610.0000
Net Interest Income
-29,968.0000
-26,564.0000
-22,509.0000
-22,630.0000
EBIT
71,559.0000
85,715.0000
92,795.0000
49,792.0000
EBITDA
93,300.0000
106,785.0000
110,725.0000
67,746.0000
Reconciled Cost of Revenue
60,096.0000
59,380.0000
55,321.0000
49,502.0000
Reconciled Depreciation
21,741.0000
21,070.0000
17,930.0000
17,954.0000
Net Income from Continuing Operation Net Minority Interest
15,778.0000
36,555.0000
53,762.0000
14,237.0000
Total Unusual Items Excluding Goodwill
276.0000
276.0000
--
--
Total Unusual Items
276.0000
276.0000
--
--
Normalized EBITDA
93,024.0000
106,509.0000
110,725.0000
67,746.0000
Tax Rate for Calcs
0.0004
0.0003
0.0002
0.0004
Tax Effect of Unusual Items
100.6720
70.7312
--
--
6/30/2021 - 7/10/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade